Delivery Order SPE2DB20D1109-SPE2DB22FN04K

Award Date 11/9/21
Potential Completion Date 11/10/21
Potential Value $2.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of 4,566,768,044 units of oxycodone hydrochloride 5 mg tablets. The $1,617.80 firm fixed price contract was awarded on December 19, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 20, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price valued at $1,347.18. The award was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,564,167,843 units of Oxycodone HCl (IR) 5 mg tablets. The contract has an ultimate completion date of March 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,460.22, is for the delivery of 4,567,012,938 units of 5 mg Oxycodone HCL immediate-release tablets. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,814,520 units of Oxycodone HCL (IR) 5 mg tablets in 100-count bottles, with a total ceiling value of $1,532.87. The contract is a firm-fixed-price delivery order, with an ultimate completion date of June 6, 2024. This contract is not designated as a set-aside....
This federal contract award is for the delivery of Oxycodone HCL 5 mg tablets to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The $3,605.83 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order issued under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award, valued at $1,162.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order and has a firm fixed price pricing type, with an ultimate completion date of March 28, 2025. The contract covers the delivery of 4567720782 units of Oxycodone HCL (IR) 5 mg tablets, a critical pain management medication, to support federal healthcare programs....
This federal contract award is for the delivery of 4,566,581,879 units of 80mg Oxycontin ER tablets to the Defense Logistics Agency (DLA). The $3,432.48 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 2, 2024, with an ultimate completion date of December 3, 2024. The contract is not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, was awarded a $1,402.56 firm fixed price delivery order for the supply of 4,563,555,240 units of oxycodone-acetaminophen 10-325 mg tablets to the Defense Logistics Agency (DLA). This delivery order is part of an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide a wide range of...
This federal contract award, valued at $1,884.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,250,443 units of Oxycodone Hydrochloride 5 mg/5 ml oral solution, a pharmaceutical product used for pain management. This is a firm-fixed price delivery order contract that runs through February 13, 2025. No set-aside designation was used for this award....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,850,528 Oxycontin ER 10 mg tablets in 100-count bottles. The $1,377.50 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) on June 7, 2024, with a completion date of June 10, 2024. This award does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a substantial Indefinite Delivery Contract (IDC) valued...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB22FN04K
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides 4,555,372,493 units of Oxycodone HCL 5 mg tablets to the Defense Logistics Agency (DLA). The $2,257.83 firm fixed-price delivery order has a completion date of November 10, 2021. The contract is not designated as a set-aside.

Amerisourcebergen, a subsidiary of Cencora, Inc., holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These IDCs enable the efficient procurement of essential pharmaceutical and medical commodities for federal agencies, including the Department of Defense and Department of Veterans Affairs.

Generated 2/27/25, 11:25 AM